Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Read more breaking news



Open pharma – regulator talks “critically important” to ending shortages; FDA

By Nick Taylor , 11-Jun-2012
Last updated on 11-Jun-2012 at 09:50 GMT2012-06-11T09:50:52Z

Open pharma – regulator talks “critically important” to ending shortages; FDA

Biopharma firms can overcome a hurdle to ending drug shortages by having transparent talks with the FDA, an Agency official said.

Early communication of supply disruptions is a centrepiece of US Food and Drug Administration (FDA) plans to tackle drug shortages and the Agency is actively encouraging biopharma firms to speak up.

We’re all in the business of making good, sound, risk-based, technically-driven decisions. One of the hurdles is…open, forthright communication”, Jeffrey Baker, deputy director, office of biotechnology products at FDA, told

Baker said it is “critically important” drugmakers play their part in ending shortages by partnering with the FDA and keeping it informed of any potential disruptions to supply. By understanding their manufacturing capabilities drugmakers can foresee problems and give the FDA advanced warning.

It all starts with thoroughly understanding processes and thoroughly understanding the capabilities and constraints of their manufacturing. When they have that understanding [manufacturers will] be able to anticipate and hopefully prevent drug shortages”, Baker said.

Related products

Happy Holidays 2014 from William Reed Business Media!

The holidays are fast upon us, so let’s put ‘business’ to one side and...

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Missy Lowery

Marketing Manager for the Americas, Capsugel

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Cory Stevenson & Brandon Pence

Thermo Fisher Scientific

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

Eric Isberg

Global Product Manager, ATMI

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the...

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

John Giannone - incoming IPEC-Americas chairman

Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

Walter Dissinger

President , BASF nutrition and health

Optimism is returning to the pharma fine chemicals sector, says analyst

Jan Ramakers

Industry consultant, Jan Ramakers Fine Chemical Consulting Group

Capsugel expands liquid fill capsule capabilities

Keith Hutchison,

Senior VP of research and development (R&D) , Capsugel

New filtration tech boosts biomanufacturing yields, says Sartorius

Jens Meyer

Product manager for filtration technologies, Sartorius Stedim

Submit good REMS proposals for FDA brownie points, says RAPS author

Ed Tabor

VP of strategic drug development , Quintiles

Key Industry Events


Access all events listing

Our events, Shows & Conferences...